🎁 Black Friday: up to 50% off of annual plans
OK Biotech Co., Ltd. (TPE:4155)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST

OK Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
251.0382.4593.982.95143.4643.46
Depreciation & Amortization
89.2192.6272.1575.5567.8855.78
Other Amortization
110.27000.1
Loss (Gain) From Sale of Assets
2.32-2.96-2.31-2.78-1.4-0.92
Asset Writedown & Restructuring Costs
----6-
Loss (Gain) From Sale of Investments
5.75-1.416.97-2.332.442.37
Loss (Gain) on Equity Investments
-2.72-0.58-5.11-5.33-7.43-24.65
Stock-Based Compensation
13.9514.6919.643.26-3.4
Provision & Write-off of Bad Debts
-63.4411.24-10.4521.2531.276.68
Other Operating Activities
56.89-13.0552.81-43.4555.052.35
Change in Accounts Receivable
-40.3165.45-41.92-77.45-71.36-92.09
Change in Inventory
47.7870.83-41.1428.9-47.31-26.57
Change in Accounts Payable
44.91-77.7-80.74-45.516.132.85
Change in Unearned Revenue
57.02-25.4-41.8822.4913.9613.72
Change in Other Net Operating Assets
29.121.6817.3725.3841.865.4
Operating Cash Flow
492.52318.8665.92.93240.5321.9
Operating Cash Flow Growth
416.49%383.83%2146.95%-98.78%998.49%-85.23%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-228.96-409.14-376.69-429.68-286.84-79.06
Sale of Property, Plant & Equipment
6.24.177.4412.115.093.11
Cash Acquisitions
---136.91---
Sale (Purchase) of Intangibles
-3.07-0.34-0.44-7.4-7.4-7.41
Investment in Securities
2.26232.2666.6-5-61.03
Other Investing Activities
2.754.8129.42-0.01-0.08-30.08
Investing Cash Flow
-234.52-398.5-444.93-358.38-294.23-174.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,3501,2701,7801,7451,282
Long-Term Debt Issued
-294.4239.8-294.87292.28
Total Debt Issued
2,4833,6441,5101,7802,0401,574
Short-Term Debt Repaid
--3,360-1,120-1,811-1,746-1,267
Long-Term Debt Repaid
--68.88-13.78-12.6-148.36-17.02
Lease Payments
-9.14-12.87-4.16-3.11-3.7-4.18
Total Debt Repaid
-2,560-3,429-1,134-1,823-1,895-1,284
Net Debt Issued (Repaid)
-77.3215.52375.99-43.3145.2290.3
Issuance of Common Stock
---270-27.24
Repurchase of Common Stock
-79.3-33.31----
Common Dividends Paid
-0.01-43.79--144.64-94.93-131.85
Other Financing Activities
2.7-24.68-37.97---
Financing Cash Flow
-153.91113.75338.0382.0650.27185.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
5.482.9-4.58---
Net Cash Flow
109.5737.02-45.58-273.39-3.4433.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
263.56-90.28-310.79-426.74-46.31-57.16
Free Cash Flow Growth
------
Free Cash Flow Margin
15.30%-5.80%-18.61%-35.80%-3.12%-4.52%
Free Cash Flow Per Share
2.07-0.69-2.37-3.71-0.40-0.54
Levered Free Cash Flow
300.04-129.4-443.16-526.99-150.13-261
Unlevered Free Cash Flow
305.58-122.58-439.27-521.37-142.99-255.95
Free Cash Flow After Leases
254.42-103.15-314.95-429.85-50.01-61.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.1110.115.195.634.563.88
Cash Income Tax Paid
35.2735.27-8.9971.3611.7739.26
Change in Working Capital
138.54134.86-162.05-46.19-56.75-66.68